Association of Race with Cumulative Exposure to Statins in Dialysis | Zendy

James B. Wetmore | Zendy; Jonathan D. Mahnken | Zendy; Sally K. Rigler | Zendy; Edward F. Ellerbeck | Zendy; Purna Mukhopadhyay | Zendy; Qingjiang Hou | Zendy; Theresa I. Shireman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Race with Cumulative Exposure to Statins in Dialysis

Author(s) -

James B. Wetmore,

Jonathan D. Mahnken,

Sally K. Rigler,

Edward F. Ellerbeck,

Purna Mukhopadhyay,

Qingjiang Hou,

Theresa I. Shireman

Publication year - 2012

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000339626

Subject(s) - medicine , statin , dialysis , medical prescription , odds ratio , confidence interval , medicaid , kidney disease , cohort , prescription drug , logistic regression , health care , pharmacology , economics , economic growth

Patients on dialysis have high rates of cardiovascular disease and are frequently treated with HMG-CoA reductase inhibitors. Given that these patients have insurance coverage for medications as well as regular contact with health care providers, differences by race in exposure to statins over time should be minimal among patients who are candidates for the drug.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research